InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,762.48
(
0.42%
)
US TECH 100
19,506.00
(
0.18%
)
Dow Jones
42,330.15
(
0.04%
)
Brent Oil
71.84
(
0.18%
)
Bitcoin
63,788.94
(
-2.80%
)
Post# of 470505
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Doc328

Send PM Follow Ignore
Followers 67
Posts 2204
Boards Moderated 0
Alias Born 03/04/2018

Doc328

Re: boi568 post# 299354

Wednesday, 02/17/2021 8:32:36 AM

Wednesday, February 17, 2021 8:32:36 AM

Post# of 470505
I'm sure the analyst is aware that AVXL is studying AD. Besides the first trial still enrolling, he was likely taking into account the necessity of a second large AD trial for approval, bringing earliest possible revenue for AD into 2025. After the 2b/3 reports and the timeline clears, they will include AD (assuming good results). If Pediatric Rett enrolls well and succeeds bigly then revenues could start 4Q2022-1Q2023 as a rare orphan indication can be approved with a single study.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM

Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM

Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM

North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM

CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM

Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM

Start posting your company's news
Only $200 per official company press release!